http://www.eurekalert.org/pub_releases/2010-12/jtcc-jtc120310.php
John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
MLN8237, Investigational Aurora A Kinase (AAK) Inhibitor in Patients with Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndromes (MDS)
15.12.2006